The present disclosure lies in the general field of clinical electrocardiography (ECG), more specifically in ECG methods comprising precordial ECG amplitude measurements. The present invention relates to methods of determining a subject's corrected precordial ECG amplitude from an ECG measurement, which corrections are based on intraindividual changes such as the rotation position of the heart on the horizontal plane, and/or changes in body mass index. The methods are thus useful for adjustment of intraindividual changes over time in precordial ECG amplitudes, such as between two ECG measurements. The present invention further relates to a device, an apparatus and a computer program product, and to uses of said device, apparatus and computer program product in a method of determining a subject's corrected precordial ECG amplitude from an ECG measurement, and for improving the accuracy of electrocardiographic methods depending on precordial ECG amplitude measurements. For example, the methods and the device, apparatus or product can be advantageously used in a method of diagnosing left ventricular hypertrophy and/or hypertension in a subject.

Systems and methods are provided for water resistant connectors. A male connector includes a rib or a draft angle that creates a seal when engaged with a female connector. A male connector includes an overmold that includes or is made of a thermoplastic elastomer. Male or female connectors include molds that include or are made of a thermoplastic polymer, such as polypropylene. A female connector includes spring contacts that fit within individual pockets of the female connector.

Systems, devices and methods for advanced electrode management in neurological monitoring applications include receiving sockets configured to receive connectors having groups of electrodes. The physician is not required to manually map each electrode with its corresponding input channel. Electrodes are coupled to the corresponding input channels in groups through connectors having a unique identification (ID). The system is configured to read the unique ID of each connector and establish its identity. Based on the ID, the system configures itself to automatically correlate or associate each electrode with its corresponding input channel when the connectors are first inserted into the receiving sockets, and again if the connectors are removed and re-inserted into different positions in the receiving sockets, to insure the electrodes are always mapped to the same input channels.

The present invention refers to a wearable, individual, customized and different sized technology for men and women, composed of electrodes, conductive track and airtight container for medicines, coupled to one another, and a mini electrocardiogram (ECG) apparatus containing a GSM (Global System Mobile) modem and a GPS (Global Positioning System) or a Bluetooth system which, through a wireless network specification within a personal scope (Wireless Personal Area NetworksPANs) deemed as PAN-type or even WPAN, the electrical signal acquisition begins when the user press the button down. It is in the field of medical, recreational and/or sport applications, aiming at monitoring patients at high cardiovascular risk, being possible to diagnose it as soon as possible, aiming at shortening time to definite treatment of those who present acute coronary syndrome (ACS), acute myocardial infarction (AMI), acute atrial fibrillation-type (AAF) cardiac arrhythmias, and other cardiac arrhythmias or other cardiac pathologies capable to be detected by the electrocardiographic trace. Moreover the invention has tools to analyze a bunch of databig data analytics and deeplearningby utilizing artificial intelligence. Finally, the invention also has a module to proper administer the drug contained into the airtight container.

An electrode padset and a method of using the electrode padset are disclosed herein. The electrode padset is a single unit, consisting of multiple patient-contacting conductive pads arranged on a single piece of material. The padset is comprised of a plurality of conductive pads, at least one conductive pad adapted to emit an electrical signal and at least one other conductive pad adapted to receive an electrical signal, and an electrically conductive material coupling the conductive pads.

Methods, noise detection devices, and differential voltage measuring systems are provided for detecting noise signals for the purpose of measuring cardiac movements in a patient. In the method, contact is made with the patient by at least two measuring electrodes having at least one associated measuring channel. Furthermore, a heartbeat measurement is performed. During the heartbeat measurement, signals from the patient are detected over the at least one measuring channel. Then, a check is made of whether the detected signals have been caused by noise by comparing the detected signals with at least one heartbeat type that was identified in the course of the learning procedure.

At least some aspects of the present disclosure direct to systems and methods for monitoring a physiological condition with a plurality of sensors. The system includes a wireless adaptor device and a wireless sensor device. The wireless adaptor device is configured to transmit wireless identification of the wireless adaptor device to the wireless sensor device via a NFC communication. The wireless sensor device is configured establish a wireless communication with the wireless adaptor device using the wireless identification of the wireless adaptor device. The wireless sensor device is further configured to transmit sensor signals to the wireless adaptor device via the established wireless communication.

A wearable medical device is provided for monitoring a cardiac condition of a patient, where the device is releasably mounted to the patient's chest and includes at least two skin-facing electrodes forming a first one or more ECG leads for ongoing monitoring of heart functioning and at least one touch electrode for intermittently obtaining additional circuit vectors for deriving additional metrics regarding the functioning of the patient's heart. Each touch electrode is configured to form an additional lead/vector that is a larger vector and/or separated by at least 15 from a corresponding first lead/vector formed from the first one or more ECG leads in a vector cardiogram representation of the first one or more ECG leads and the additional lead/vector.

A patient-worn arrhythmia monitoring and treatment device includes a pair of therapy electrodes and at least one pair of sensing electrodes disposed proximate to the skin and configured to continually sense at least one ECG signal of the patient over an extended period of time. The device includes a therapy delivery circuit coupled to the pair of therapy electrodes and configured to deliver one or more therapeutic pulses. A controller coupled to therapy delivery circuit is configured to analyze the at least one ECG signal and detect one or more treatable arrhythmias and cause the therapy delivery circuit to deliver the one or more therapeutic pulses to the patient. At least one of the one or more therapeutic pulses is formed as a biphasic waveform delivering within 15 percent of 360 J of energy to a patient body having a transthoracic impedance from about 20 to about 200 ohms.

A portable medical device having an intravenous line flow sensor integrated into a cable. The portable medical device may be a defibrillator having an ECG or electrode cable couple to ECG or electrode leads. The flow sensor may be integrated into the ECG or electrode cable. The portable medical device uses the flow sensor to capture and store information about fluids delivered to a patient being treated with the portable medical device. The information may include total volume provided, flow rate, and the like. The information may then be used to evaluate the treatment provided to the patient.